Tradestie Institutional Equity Comparison Engine

STLN vs PIII โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PIII Overall Edge

PIII Captures Institutional Edge (1โ€“1 Pillars ยท 6โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to P3 Health Partners Inc. Common Stock (PIII) driven by superior Growth & Margin while STLN counters with relative strength in Momentum & Technical. Fundamentally, STLN trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus PIII at N/M Forward P/E and -5.2% operating margin (+14.8% YoY). In options structure, STLN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PIII sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
STLN N/M vs PIII N/M Fwd P/E
Growth & Margin Winner PIII
Op Margin N/A vs -5.2% ยท YoY N/A vs +14.8%
Momentum & Technical Winner STLN
1Y -42.0% vs -71.7% ยท 52W Pos 1% vs 1%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
STLN US Equity
STLN
Institutional Equity
$3.00
-5.66% 1D
Market Cap N/A
1M Return -56.58%
1Y Return -41.97%
Forward P/E N/M
Unified AI Score
46.6 / 100 HOLD
Tech 45.0 Fund 46.0 Flow 50.0 Mom 55.0
PIII NASDAQ
P3 Health Partners Inc. Common Stock
Services-Health Services
$1.69
-9.14% 1D
Market Cap $385.5M
1M Return -61.24%
1Y Return -71.74%
Forward P/E N/M
Unified AI Score
38.6 / 100 SELL
Tech 25.0 Fund 40.0 Flow 50.0 Mom 49.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: STLN -41.97% PIII -71.74% Spread: +41.75 pp (STLN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
STLN TTM Op. Margin: N/A PIII TTM Op. Margin: -5.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on STLN vs PIII. Trailing 12-month operating profitability (STLN N/A vs PIII -5.2%) and valuation multiples (STLN N/M vs PIII N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: STLN (1) vs PIII (6)
Institutional Metric STLN PIII Criterion Row Winner
Market Capitalization Scale N/A $385.5M Larger Scale PIII
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +14.8% Higher Growth PIII
Operating Margin (TTM) Profitability N/A -5.2% Higher Margin PIII
Net Profit Margin Profitability N/A -3.3% Higher Margin PIII
Return on Equity (ROE) Capital Efficiency N/A -105.8% Higher ROE PIII
52-Week Range Position Momentum 1% ($3โ€“$7) 1% ($2โ€“$17) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 1.42ฮฒ ยท 175% Vol -0.87ฮฒ ยท 132% Vol Lower Realized Risk PIII
Unified Institutional Score Composite Signal 46.6 / 100 (HOLD) 38.6 / 100 (SELL) Higher Composite STLN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full STLN vs PIII Buy Guide
STLN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live STLN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PIII UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PIII Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither STLN nor PIII registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.